|
according to which the multinational company has initiated a due diligence process regarding the SRS system of the company for treatment of Gastro Esophageal Reflux Disease (GERD).
The due diligence is performed in order to evaluate the possibility of engaging in a strategic partnership agreement and an exclusive worldwide marketing agreement.
At present, the company cannot assess the chances of successful outcomes for the due diligence process and the negotiations.
[Non-binding translation of the company's Hebrew announcement.]
|